drug · unknown
Maci
Phase 3updated 6mo agoby $VCEL Vericel Corp🔗 ChEMBL
Phase 3community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for articular cartilage disorder and cartilage disease and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying Maci
- phase2A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast Cancer
- phase1A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer
- phase3A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
- phase3Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
- phase3Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- EP1(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
- phase2A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- phase2A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 51m ago
Found something off?
comments(0)
5-min edit window · permanent after that